New Delhi: Having yielded encouraging results in the initial phases of its trial, one of the three COVID-19 vaccine candidates would enter the third phase of the pre-clinical human trial by Wednesday, informed the Ministry of Health and Family Welfare on Tuesday.
Head of the national task force on COVID-19, Dr. V.K. Paul informed about the development during a weekly press briefing, said media reports.
While not sharing the names of the other two vaccines, Paul added that they are currently in phase-I or II of their pre-clinical trials.
India has three vaccine candidates for COVID-19 – ChAdOx1, developed by Oxford University and manufactured jointly by the Serum Institute of India (SII), Pune and AstraZeneca, Bharat Biotech’s Covaxin, jointly developed with the Indian Council of Medical Research and the third is ZycovD by Zydus Cadila.
Kolkata: A day after a female contractual employee of Raj Bhavan lodged a police complaint accusing…
Bhubaneswar: The ruling Biju Janata Dal (BJD) on Friday has unveiled its roster of 40…
Bhubaneswar: Odisha Real Estate Regulatory Authority (RERA) has slapped a fine of Rs 50 lakh…
New Delhi: The Supreme Court may consider granting interim bail to Arvind Kejriwal in view of…
New Delhi: Congress leader Rahul Gandhi on Friday outlined his party's vision for Odisha while…
Bhubaneswar: Amid an increase in cybercrime cases in Odisha capital, the Commissionerate Police here has…
Bhubaneswar: The India Meteorological Department (IMD) on Friday predicted an abatement in heatwave conditions in Odisha…
Bhubaneswar: BJP national president J P Nadda will again visit Odisha on May 5 to…